GLUL and hepatocellular carcinoma: However, stimulation of TKO HCC cells with Wnt3a ligand increased glutamine synthetase (GS; a clinical marker for Wnt activity in the liver40) expression (Fig. 3f), indicating that Wnt pathway can be activated in TKO HCC.